The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms.

The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms.

Item
http://www.wikidata.org/entity/Q37861186
Dasatinib-loaded albumin nanoparticles possess diminished endothelial cell barrier disruption and retain potent anti-leukemia cell activityGefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.A Case of Chronic Lymphocytic Leukaemia Occurring During Treatment of Chronic Myeloid Leukaemia.The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents.High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cellsSrc family kinases and their role in hematological malignancies.Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation.Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming.Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion.Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors.
P2860

The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms.

Item
http://www.wikidata.org/entity/Q37861186
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The potential for dasatinib in ...... myeloproliferative neoplasms.
@en
The potential for dasatinib in ...... myeloproliferative neoplasms.
@nl
type
label
The potential for dasatinib in ...... myeloproliferative neoplasms.
@en
The potential for dasatinib in ...... myeloproliferative neoplasms.
@nl
prefLabel
The potential for dasatinib in ...... myeloproliferative neoplasms.
@en
The potential for dasatinib in ...... myeloproliferative neoplasms.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
The potential for dasatinib in ...... myeloproliferative neoplasms.
@en
P2093
P2860
P304
P31
P356
10.3109/10428194.2011.555890
P433
P478
P577
P698
P921